These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1362 related articles for article (PubMed ID: 10673212)
1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):646-64. PubMed ID: 10673212 [No Abstract] [Full Text] [Related]
2. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ; Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710 [TBL] [Abstract][Full Text] [Related]
3. Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis. Peckham RM; Shorr AF; Helman DL Respiration; 2004; 71(2):165-9. PubMed ID: 15031572 [TBL] [Abstract][Full Text] [Related]
4. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med; 1999 Aug; 160(2):736-55. PubMed ID: 10430755 [No Abstract] [Full Text] [Related]
5. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. ; Am J Respir Crit Care Med; 2002 Jan; 165(2):277-304. PubMed ID: 11790668 [No Abstract] [Full Text] [Related]
6. [Idiopathic pulmonary fibrosis. II. Treatment]. Lode H; Erbes R; Raffenberg M Dtsch Med Wochenschr; 2001 Apr; 126(14):399-401. PubMed ID: 11332243 [No Abstract] [Full Text] [Related]
7. [Increasing dyspnea: myocardial infarction anamnesis led to wrong track]. Stiefelhagen P MMW Fortschr Med; 2005 Feb; 147(8):14. PubMed ID: 18441558 [No Abstract] [Full Text] [Related]
11. [Idiopathic pulmonary fibrosis; description of a Dutch cohort]. Barlo NP; van Moorsel CH; van den Bosch JM; van de Graaf EA; Kwakkel-van Erp JM; Grutters JC Ned Tijdschr Geneeskd; 2009; 153():B425. PubMed ID: 19785823 [TBL] [Abstract][Full Text] [Related]
18. Idiopathic interstitial pneumonias: a re-appraisal of idiopathic pulmonary fibrosis. Taylor DA; du Bois RM Int J Tuberc Lung Dis; 2001 Dec; 5(12):1086-98. PubMed ID: 11769766 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of idiopathic pulmonary fibrosis]. Dury S Rev Mal Respir; 2006 Apr; 23(2 Pt 2):5S87-5S91. PubMed ID: 16788517 [No Abstract] [Full Text] [Related]
20. Idiopathic pulmonary fibrosis in a child. Chang KW; Wu CT; Huang SF; Jiang TH; Wong KS Chang Gung Med J; 2003 Jan; 26(1):60-4. PubMed ID: 12656311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]